Healthcare savings associated with reduced infection rates using antimicrobial suture wound closure for cerebrospinal fluid shunt procedures

Pediatric Neurosurgery

Volumn 46, Issue 1, 2010, Pages 19-24

  Stone, Jonathan ^a   Gruber, Thomas J ^a   Rozzelle, Curtis J ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antimicrobial suture; Cerebrospinal fluid shunt; Cost; Infection; Infection prevention

Indexed keywords

ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID SHUNTING; FOLLOW UP; HEALTH CARE; HEALTH CARE FINANCING; HOSPITAL CHARGE; HOSPITALIZATION; HUMAN; INFECTION RATE; LENGTH OF STAY; MAJOR CLINICAL STUDY; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; SHUNT INFECTION; SHUNTING; SUTURING METHOD; WOUND CLOSURE; CHILD; COST CONTROL; ECONOMICS; HOSPITAL; HOSPITAL COST; HYDROCEPHALUS; INFECTION CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURGICAL WOUND INFECTION;

CEREBROSPINAL FLUID SHUNTS; CHILD; COST SAVINGS; HOSPITAL COSTS; HOSPITALS, PEDIATRIC; HUMANS; HYDROCEPHALUS; INFECTION CONTROL; LENGTH OF STAY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; SUTURE TECHNIQUES;

EID: 77951941892     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314053     Document Type: Article

References (8)

1. Simon TD, Riva-Cambrin J, Srivastava R, Bratton SL, Dean JM, Kestle JR: Hospital care for children with hydrocephalus in the united states: Utilization, charges, comorbidities, and deaths. J Neurosurg Pediatr 2008; 1: 131-137.
2. Patwardhan RV, Nanda A: Implanted ventricular shunts in the united states: The billion- dollar-a-year cost of hydrocephalus treatment. Neurosurgery 2005; 56: 139-145.
3. Bondurant CP, Jimenez DF: Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 1995; 23: 254-259.
4. Rozzelle CJ, Leonardo J, Li V: Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: A prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 2008; 2: 111-117.
5. Choux M, Genitori L, Lang D, Lena G: Shunt implantation: Reducing the incidence of shunt infection. J Neurosurg 1992; 77: 875-880.
6. Eymann R, Chehab S, Strowitzki M, Steudel WI, Kiefer M: Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters. J Neurosurg Pediatr 2008; 1: 444-450.
7. Sciubba DM, Lin LM, Woodworth GF, Mc- Girt MJ, Carson B, Jallo GI: Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus 2007; 22:E9.
8. Sciubba DM, McGirt MJ, Woodworth GF, Carson B, Jallo GI: Prolonged exposure to antibiotic-impregnated shunt catheters does not increase incidence of late shunt infections. Childs Nerv Syst 2007; 23: 867-871.